Analysis of the Pharmaceutical Market in Malaysia
|出版商||Frost & Sullivan||商品編碼||332904|
|出版日期||內容資訊||英文 65 Pages
Attractiveness and Hurdles for Stakeholders in the Next 5 Years
The growing population base, driven by increased life expectancy and domestic investment, is expected to continuously accelerate GDP in Malaysia. Significant growth of healthcare expenditure is expected in the country to facilitate the improvement of medical access and provide companies with revenue-earning opportunities from 2015. Positive macroeconomic and healthcare market trends are expected to fast-track the pharmaceutical market in Malaysia. The study explores the broad competitive landscape, demand dynamics, and regulatory environment that investors must consider while entering this pharmaceutical market.